Trial intelligence / Profile preview

CINCH-UC: Nesiritide in Chronic Heart Failure

NCT00145873Phase 2Terminated

Sponsor
University of Chicago
Start
Aug 2003
Primary completion
Sep 2006
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of nesiritide in chronic heart failure (CHF), sponsored by University of Chicago. Started Aug 2003; status: terminated.

02

Drugs

nesiritide
03

Conditions

chronic heart failure (CHF)

Beyond the preview

Go deeper on NCT00145873.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00145873.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call